KPMG International, Inc.

8 articles about KPMG International, Inc.

• Strong Quarter Defies Expectations as Venture Capital Invested Rises Despite Six-Quarter Decline in Deal Volume, Says KPMG Private Enterprise

  10/21/2020

  In the face of concerns related to COVID-19, geopolitical tensions, the upcoming US presidential election, and a potential hard Brexit, global VC investment actually rose for the second straight quarter – reaching $73.2 billion in Q3’20, according to the Q3’20 edition of Venture Pulse – a quarterly report published by KPMG Private Enterprise on global VC trends.

• COVID-19 Worsening Mental Health Of 59% Of Healthcare Industry Workers: KPMG Survey

  5/15/2020

  Employees point to improved quality of work, collaboration, stronger ties to company and co-workers

• UTILITY therapeutics signs license agreement with LEO Pharma A/S for US rights to mecillinam and pivmecillinam

  5/15/2018

  UTILITY therapeutics Ltd (“UTILITY” or “the Company”), a pharmaceutical company focused on developing and commercialising antibiotics in the US, today announces the signature of an exclusive license agreement for the antibiotics mecillinam and pivmecillinam with LEO Pharma A/S.

• Surveys Of Pharma Execs See More Rocky Times Ahead, KPMG International, Inc. Reveals

  7/14/2011

• Yongye Biotechnology International Appoints KPMG International, Inc. as New Independent Auditor

  5/26/2009

• Genesis Pharmaceutical, Inc. Appoints KPMG International, Inc. to Help Develop a SOX 404 Compliance Program

  1/13/2009

• KPMG LLP Joins GaBio as $50,000 Champion Sponsor To Boost Georgia's Growing Life Sciences Industry

  3/10/2008

• KPMG International, Inc. More JVs in 2008, Less M&A

  2/8/2008